ORAL-CONTRACEPTIVE PILLS AND ENDOMETRIAL CANCER

被引：0
|
作者：
ACHESON, LS
机构：
来源：
ANNALS OF INTERNAL MEDICINE | 1979年 / 91卷 / 05期
关键词：
D O I：
10.7326/0003-4819-91-5-793_2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：793 / 793
页数：1
相关论文
共 50 条
  • [31] ORAL-CONTRACEPTIVE USE AND BREAST-CANCER
    BAULIEU, EE
    BENAGIANO, G
    BROSENS, I
    COOKE, ID
    GOLDZIEHER, JW
    HAMMERSTEIN, JW
    HASPELS, A
    JOHANNISSON, E
    LUNENFELD, B
    POTTS, M
    BRITISH JOURNAL OF CANCER, 1987, 56 (05) : 706 - 706
  • [32] ORAL-CONTRACEPTIVE USE AND LIVER-CANCER
    PALMER, JR
    ROSENBERG, L
    KAUFMAN, DW
    WARSHAUER, ME
    STOLLEY, P
    SHAPIRO, S
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1989, 130 (05) : 878 - 882
  • [33] ORAL-CONTRACEPTIVE AGENTS
    GLASS, RH
    WESTERN JOURNAL OF MEDICINE, 1975, 122 (01): : 66 - 67
  • [34] CHOICE OF AN ORAL-CONTRACEPTIVE
    LANGER, A
    DEVANESAN, M
    PELOSI, MA
    APUZZIO, JJ
    FRATTAROLA, M
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1976, 126 (02) : 153 - 157
  • [35] ORAL-CONTRACEPTIVE FOR MEN
    BRIGGS, M
    BRIGGS, M
    NATURE, 1974, 252 (5484) : 585 - 586
  • [36] ORAL-CONTRACEPTIVE HYPERTENSION
    LARAGH, JH
    POSTGRADUATE MEDICINE, 1972, 52 (03) : 98 - &
  • [37] FIBRINOLYTIC-ACTIVITY IN WOMEN ON ORAL-CONTRACEPTIVE PILLS - VARIATION DUE TO HEMOGLOBIN GENOTYPE
    FAMODU, AA
    ERHUNMWUNSE, RU
    ELOM, EU
    ACTA TROPICA, 1992, 52 (2-3) : 135 - 138
  • [38] ORAL-CONTRACEPTIVE HAZARDS
    不详
    PHARMACY INTERNATIONAL, 1980, 1 (03): : 51 - 52
  • [39] DANAZOL AS AN ORAL-CONTRACEPTIVE
    LAUERSEN, NH
    WILSON, KH
    FERTILITY AND STERILITY, 1977, 28 (03) : 289 - 289
  • [40] ENDOMETRIAL ADENOCARCINOMA - ESTROGEN, ORAL-CONTRACEPTIVE AND NON-HORMONE USERS
    BLYTHE, JG
    ALI, Z
    GYNECOLOGIC ONCOLOGY, 1979, 7 (02) : 199 - 205
12345